The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the “idiopathic” and ...

Prominent biotech Biogen ( BIIB +5.94%) loomed large on the stock market on Wednesday. It published its latest set of ...

ANL shifts to early RAS-targeting and immuno-oncology after Phase 3 failure; PIPE/ASK funding boosts cash. Click here to read ...

Here are the stocks making headlines in midday trading. Regeneron — The biotech stock slid nearly 6% after the company ...

The world urgently needs new antibiotics, yet the market routinely punishes companies that take on the long, risky and ...

Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the 10 best biotech stocks with highest upside potential. On April 6, Denali ...

As of the April 24 closing, the stock carries a strongly bullish consensus sentiment. With a price target of $86.71, it ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

These six stocks pay dividend yields between 7% and nearly 12%. Find out who they are and why they have such generous ...

Regeneron Pharmaceuticals' board has added $3 billion to the biotechnology company's stock-buyback program. Regeneron on Wednesday said the new authorization adds to the $688 million remaining under ...

Alexandria Real Estate Equities, the largest lab REIT, experienced a significant slowdown in leasing activity at its ...

Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit ...